This is a community-generated profile. If you would like to claim it, please .
Advantagene Funding
$0
22 rounds
Advantagene is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on April 21, 2016.
Funding Rounds
U
$35000000U
$500000UnknownMay 2011
Investors of Advantagene
Massachusetts Life Sciences Center
Funds life science innovation, research, and manufacturing
Rounds
U